Cargando…
Microbiome: an emerging new frontier in graft‑versus‑host disease
Autores principales: | Kumari, Reena, Palaniyandi, Senthilnathan, Strattan, Ethan, Hildebrandt, Gerhard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661320/ https://www.ncbi.nlm.nih.gov/pubmed/33185704 http://dx.doi.org/10.1007/s00011-020-01419-w |
Ejemplares similares
-
Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
por: Kumari, Reena, et al.
Publicado: (2020) -
Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2019) -
Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2021) -
S242: MAST CELLS ARE MEDIATORS OF INFLAMMATORY EFFECTOR CELL RECRUITMENT AND FIBROSIS IN DERMAL CHRONIC GRAFT-VERSUS-HOST DISEASE
por: Palaniyandi, Senthilnathan, et al.
Publicado: (2023) -
Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)